MTEX Mannatech Inc.

Mannatech Finds Most Aloe Vera Products Are Missing This Key Feature That Makes the Difference to Your Health

Mannatech®, Incorporated (NASDAQ: MTEX), which provides top-quality nutritional supplements for families in China through its website www.MeiTaiChina.com, provides one of the rarest derivatives of the legendary aloe vera plant that serves as the basis for many of its innovative health and wellness products.

For more than 20 years, Mannatech has included a pure, exclusively refined ingredient derived from the gel of the aloe vera plant called “Manapol® powder.” Manapol powder is an essential ingredient in core Mannatech Glyconutritional products. Mannatech’s Advanced Ambrotose® powder and Ambrotose Complex powder are among the company’s top-selling products containing this aloe vera gel extract, and are known for their cognitive, immune and gastrointestinal benefits as well as cellular communication support.

There are many companies that sell products based on aloe vera gel. Some make boastful claims about what their products can do, but what most of these companies are missing are the clinical trials that scientifically validate their products. This is just one of a number of advantages that Mannatech provides its customers compared to almost all of its competitors, which helps to ensure that the wellness promises made are real and substantiated.

Since its founding, Mannatech has invested more than $50 million in research and development that includes a clinical testing program for its nutritional technology. In fact, Mannatech’s product technology has been the subject of 17 human clinical trials that have been published, 12 of which were double-blind, placebo-controlled studies—the gold standard for product validation.

With Mannatech’s rigorous testing and quality controls, its products are known for their effectiveness at supporting the health and wellness of its customers.

“Mannatech takes great pains to ensure that we provide scientifically-backed product technology that is clinically tested. This is critical for our products that include aloe vera because we want to ensure we are delivering what we promise,” said Alfredo “Al” Bala, CEO and President of Mannatech. “Customers of many other companies are taking a gamble on the effectiveness of their purchases, but with Mannatech, there is no such risk. We have the best suppliers, quality controls from the farm to the finished product and clinical trials to support the safety and efficacy of our product technology that few can match. Our message is that, if the company you purchase your aloe vera-based supplements from hasn’t conducted clinical trials, you should be wary of what is being claimed and what you are buying.”

Mannatech takes extraordinary steps to provide its customers with real, beneficial aloe vera-based products. This includes transparency down to the plant in the ground. A big part of the transparency promise Mannatech makes is tied to the technology and supply Mannatech has painstakingly developed through the years. For example, recently Mannatech announced it has secured its continuing source of premium Manapol powder with an exclusive deal with Natural Aloe Costa Rica.

Finally, the company is proud to have a Global Scientific Advisory Board, made up of physicians, scientists and researchers from around the world. These experts take part in Mannatech’s commitment to scientific validation and ensure that its customers have top scientific minds supporting their needs.

For more information about Mannatech and its products, please visit www.MeiTaiChina.com.†

About Mannatech

Mannatech, Incorporated, offers a profound wellness experience that makes a difference in the lives of people across the world. Through its innovative Glyconutrition products, Mannatech changes lives, providing an unprecedented level of natural wellness, freedom and purpose. With more than 20 years of experience and operations in 26 markets^, Mannatech is committed to transforming lives. For more information, visit www.MeiTaiChina.com.

Read more about Mannatech’s forward-looking statements.

†Customers who invite other customers to the Mannatech China cross border e-commerce site gain rewards for future product purchases or cash redemption. The e-commerce business model is not multi-level marketing or direct selling.

^Mannatech’s cross-border e-commerce model in China is a different opportunity from Mannatech’s MLM business in other markets. Our cross-border e-commerce model in China is not an MLM or direct selling business.

EN
08/06/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Mannatech Inc.

 PRESS RELEASE

Mannatech Announces Appointment of Robert A. Toth as Vice Chairman of ...

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ) announced that on November 20, 2024, the Board of Directors of Mannatech, Incorporated (the “Board”) appointed Robert A. Toth to the Board where he will serve as Vice Chairman of the Board of Mannatech, Incorporated (the "Company") effective December 1, 2024. Mr. Toth will serve as a Class III director of the Board. Mr. Toth previously served on the Company's Board between March 2008 through May 31, 2023. Mr. Toth previously served as the Chairman of the Compensation and Stock Option Plan Committee, served on the Audit Committee, the Nominat...

 PRESS RELEASE

Mannatech Reports Financial Results for Third Quarter 2024

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its third quarter of 2024. Third Quarter Highlights Net sales for the quarter ended September 30, 2024 were $31.7 million, as compared to $32.6 million for the same period in 2023, a decrease of $0.9 million, or 2.5%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $0.4 million, or 1.2%, and unfavorable foreign exchange caused a $0.5 million decrease...

 PRESS RELEASE

Mannatech Reports Financial Results for Second Quarter 2024

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ), ("Mannatech" or "Company"), global health and wellness company committed to transforming lives to make a better world, today announced financial results for its second quarter of 2024. Second Quarter Highlights Net sales for the quarter ended June 30, 2024 were $27.7 million, as compared to $32.6 million for the same period in 2023, a decrease of $4.9 million, or 14.9%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $4.2 million, or 12.9%, and unfavorable foreign exchange caused a $0.7 million decrease ...

 PRESS RELEASE

Mannatech Announces Appointment of James Clavijo as Chief Financial Of...

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ) announced that the Board of Directors appointed James Clavijo as Chief Financial Officer of Mannatech Incorporated (the "Company") effective July 1, 2024. James Clavijo brings over 25 years of experience in executive, finance, and accounting activities. He has served as CFO for biotech, medical technology, and pharmaceutical companies, including Longeveron (NASDAQ: LVGN), Guided Therapeutics (OTC: GTHP), Aeterna Zentaris (NASDAQ: AEZS), and Tri-source Pharma. Mr. Clavijo has led and advised companies with strategic plans for pharmaceutical c...

 PRESS RELEASE

Mannatech Reports Financial Results for First Quarter 2024

FLOWER MOUND, Texas--(BUSINESS WIRE)-- (NASDAQ: ), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its first quarter of 2024. First Quarter Highlights Net sales for the quarter ended March 31, 2024 were $29.4 million, as compared to $34.1 million for the same period in 2023, a decrease of $4.7 million, or 13.8%. On a Constant dollar basis (see Non-GAAP Measures, below) our net sales decreased $3.9 million, or 11.3%, and unfavorable foreign exchange caused a $0.8 million decrease in GAAP net sales as compar...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch